Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors

PURPOSE: Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme important in DNA repair. PARP-1 activation at points of DNA strand break results in poly(ADP-ribose) polymer formation, opening the DNA structure, and allowing access of other repair enzymes. CEP-9722 inhibits PARP-1 and PARP-2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Plummer, Ruth, Stephens, Peter, Aissat-Daudigny, Louiza, Cambois, Anne, Moachon, Gilbert, Brown, Peter D., Campone, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112042/
https://www.ncbi.nlm.nih.gov/pubmed/24880570
http://dx.doi.org/10.1007/s00280-014-2486-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112042/
https://www.ncbi.nlm.nih.gov/pubmed/24880570
http://dx.doi.org/10.1007/s00280-014-2486-9

Ejemplares similares